Legal entity

Brookings Institution

organization

Every one of those 1 sits in a single category, regulation. House Select Committee on China is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 8 average consequence score is above the beat benchmark of 6.5 in the same window.

Last mentioned: Jul 9, 2026

Entity pulse

Recent coverage · Brookings Institution

1 story
8 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Brookings Institution

Every one of those 1 sits in a single category, regulation. House Select Committee on China is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 8 average consequence score is above the beat benchmark of 6.5 in the same window. They are better corroborated than the beat average, carrying 3 original sources each against 2.3 for the same window. We currently track 1 Legal story that mention Brookings Institution, all published on March 19, 2026.

Stories tracked
1
Sources per story
3

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 45 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Brookings Institution. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Brookings Institution 1

Regulation Negative

US Lawmakers Warn of Strategic Risk in Chinese Pharmaceutical Dependency

The House Select Committee on China has raised alarms over the United States' increasing reliance on Chinese-made active pharmaceutical ingredients and biotech innovation. Lawmakers argue that Beijing is applying a proven industrial playbook to dominate the global medicine supply chain, posing significant national security and regulatory challenges.

3 sources

Source: Lucy Quaggin (cn) · Lucy Quaggin (hk)

Brookings Institution is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.